據報保監局張雲正遭舉報 與泰加保險(06161.HK)前高層存利益衝突
《香港01》引述消息報道,保監局4月收到至少兩宗舉報,指控保監局行政總監張雲正與泰加保險(06161.HK)一名前高層疑存在利益關係,於泰加保險的調查中存在利益衝突。
據悉,保監局於6月1日發出的信件顯示,張雲正「沒有、將來亦不會」參與對泰加的調查工作,而局方正跟進有關舉報。張雲正於6月中飛往克羅地亞出席6月16及17日舉行的國際保險監督官協會研討會,其後因感染新冠病毒而未回港。
保監局指出,泰加保險(控股)早前已就保監局委任經理接管泰加保險的決定向保險事務上訴審裁處提出覆核申請,局方不會對事件作出進一步評論。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.